episode-header-image

Apr 2023

8m 16s

208. #VESSIE IMMUNOTHÉRAPIE PÉRIOPÉRATOI...

About this episode

Up next

217. LASER DOPÉS AU THULIUM : AVANTAGES ET PERSPECTIVES DANS LA PRISE EN CHARGE DE CALCULS URINAIRES - DR PANTHIER

217. LASER DOPÉS AU THULIUM : AVANTAGES ET PERSPECTIVES DANS LA PRISE EN CHARGE DE CALCULS URINAIRES - DR PANTHIERQu'est-ce qu'un laser thulium ?Quels sont les avantages du laser thulium fibré par rapport au laser holmium-YAG ?Quels sont les lasers recommandés en 2024 pour traite ... Show More

216. IDENTIFICATION ET PRISE EN CHARGE DES MALADIES LITHIASIQUES HEREDITAIRES - PROFESSEUR HAYMANN

216. IDENTIFICATION ET PRISE EN CHARGE DES MALADIES LITHIASIQUES HEREDITAIRES - PROFESSEUR HAYMANNQuand faut-il suspecter les maladies lithiasiques héréditaires ? Comment les identifier ? De quels outils dispose t-on et quelles sont les recommandations diététiques et thérapeutiqu ... Show More

215. PERSPECTIVES POUR 2024 DANS LE CANCER DE PROSTATE MÉTASTATIQUE - PROFESSEUR FIARD

215. PERSPECTIVES POUR 2024 DANS LE CANCER DE PROSTATE MÉTASTATIQUE - PROFESSEUR FIARDQuelles perspectives pour le traitement du cancer de la prostate hormonosensible ?Quelles perspectives 2024 au stade de résistance à la castration ?Quelles questions restent en suspens en ce déb ... Show More

Recommended Episodes

40 - Infectious Cancer Therapy

The Curious Clinicians examine why we use a bacterial vaccine (BCG, an attenuated form of mycobacterium bovis) to treat an unrelated malignancy (bladder cancer). Check out the show notes here. Click here to obtain AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance ... Show More

Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ... Show More

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer Guest: Jeffrey M Holzbeierlein, MD Outline: Segment #1: Guideline Statement 9-Patients who have not received cisplatin-based NAC and have pT3-4 and/or N= disease at cystectomy should receive adjuvant c ... Show More

Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More

التهاب المثانة المتكرر... ما الأسباب وما العلاج

<p>This episode covers bladder cancer.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/surgery/urology/bladdercancer/'>https://zerotofinals.com/surgery/urology/bladdercancer/</a> or in the urology section of the Zero to Finals surgery book.</p><p>The audi ... Show More

<p>Today’s episode is focusing on bladder cancer - what you need to know about the pathology, presentation, diagnostic work-up, staging, treatment, and rarer upper GU tract presentations.</p>

Immunotherapy in TNBC: What's New, What's Next?

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More

66. Urology 101: Urinary Tract Infections

In this episode, Dr Keith Rourke discusses urinary tract infections. After listening to this episode, listeners will be able to: - describe the signs, symptoms and treatment of bacterial cystitis and pilonephritis - develop an approach to treating patients with both complicated a ... Show More

Prof. James Catto (GB) shares results of THOR-2 cohort 1 study

<p>In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. James Catto (GB) about the THOR-2 cohort 1 study: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) with ... Show More